Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Roth

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Modern Rheumatology|December 16, 2021
Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation studyYoshiya Tanaka, Paula Curtis, Kathleen DeRose, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 7, 2018
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United StatesRichard A Furie, Daniel J Wallace, Cynthia Aranow, et al.
Human Gene Therapy|December 9, 2004
Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirusDavid M Roth, N Chin Lai, Mei Hua Gao, et al.
Annals of the Rheumatic Diseases|January 4, 2018
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South KoreaFengchun Zhang, Sang-Cheol Bae, Damon Bass, et al.
Lupus Science & Medicine|August 29, 2022
Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus CohortSelin Cooper Blenkinsopp, Qinggong Fu, Yulia Green, et al.
Lupus|October 7, 2022
Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial dataDaniel J Wallace, Tatsuya Atsumi, Mark Daniels, et al.
Human Gene Therapy|February 4, 2006
Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirusDavid A Roth, M Dan McKirnan, Ilona Canestrelli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab TrialsRonald F van Vollenhoven, Michelle Petri, Daniel J Wallace, et al.
Human Gene Therapy|June 24, 2004
Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical dataMei Hua Gao, N Chin Lai, M Dan McKirnan, et al.
Environmental Science & Technology|September 2, 2017
Effects of an Extreme Flood on Trace Elements in River Water-From Urban Stream to Major River BasinLarry B Barber, Suzanne S Paschke, William A Battaglin, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Modern Rheumatology|December 16, 2021
Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation studyYoshiya Tanaka, Paula Curtis, Kathleen DeRose, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 7, 2018
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United StatesRichard A Furie, Daniel J Wallace, Cynthia Aranow, et al.
Human Gene Therapy|December 9, 2004
Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirusDavid M Roth, N Chin Lai, Mei Hua Gao, et al.
Annals of the Rheumatic Diseases|January 4, 2018
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South KoreaFengchun Zhang, Sang-Cheol Bae, Damon Bass, et al.
Lupus Science & Medicine|August 29, 2022
Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus CohortSelin Cooper Blenkinsopp, Qinggong Fu, Yulia Green, et al.
Lupus|October 7, 2022
Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial dataDaniel J Wallace, Tatsuya Atsumi, Mark Daniels, et al.
Human Gene Therapy|February 4, 2006
Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirusDavid A Roth, M Dan McKirnan, Ilona Canestrelli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab TrialsRonald F van Vollenhoven, Michelle Petri, Daniel J Wallace, et al.
Human Gene Therapy|June 24, 2004
Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical dataMei Hua Gao, N Chin Lai, M Dan McKirnan, et al.
Environmental Science & Technology|September 2, 2017
Effects of an Extreme Flood on Trace Elements in River Water-From Urban Stream to Major River BasinLarry B Barber, Suzanne S Paschke, William A Battaglin, et al.
Pageof 6